We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

1,056 hedge funds and large institutions have $96.1B invested in Allergan plc in 2015 Q3 according to their latest regulatory filings, with 121 funds opening new positions, 402 increasing their positions, 407 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more first-time investments, than exits

New positions opened: 121 | Existing positions closed: 93

15% more call options, than puts

Call options by funds: $1.73B | Put options by funds: $1.51B

2% more funds holding

Funds holding: 1,0351,056 (+21)

1% less repeat investments, than reductions

Existing positions increased: 402 | Existing positions reduced: 407

7% less capital invested

Capital invested by funds: $103B → $96.1B (-$7.12B)

11% less funds holding in top 10

Funds holding in top 10: 176157 (-19)

Holders
1,056
Holders Change
+21
Holders Change %
+2.03%
% of All Funds
29.47%
Holding in Top 10
157
Holding in Top 10 Change
-19
Holding in Top 10 Change %
-10.8%
% of All Funds
4.38%
New
121
Increased
402
Reduced
407
Closed
93
Calls
$1.73B
Puts
$1.51B
Net Calls
+$223M
Net Calls Change
+$273M
Name Holding Trade Value Shares
Change
Change in
Stake
RSCM
226
Rock Springs Capital Management
Maryland
$34.2M +$1.38M +4,500 +4%
US Bancorp
227
US Bancorp
Minnesota
$34M -$2.45M -7,975 -6%
ACP
228
Aviance Capital Partners
Florida
$33.9M +$150K +487 +0.4%
MCM
229
McKinley Capital Management
Alaska
$33.9M -$2.01M -6,533 -5%
RHBC
230
R.H. Bluestein & Co
Michigan
$33.6M -$14.3M -46,665 -27%
CCM
231
Cobalt Capital Management
New Jersey
$33.2M +$3.93M +12,800 +12%
GA
232
Geneva Advisors
Illinois
$33M +$867K +2,824 +2%
SCI
233
Seneca Capital Investments
New York
$32.8M -$1.95M -6,334 -5%
Comerica Bank
234
Comerica Bank
Texas
$32.7M +$37M +120,483 New
TEC
235
Tiger Eye Capital
Tennessee
$32.5M -$55.9M -181,910 -60%
Stifel Financial
236
Stifel Financial
Missouri
$32.1M +$631K +2,053 +2%
IGM
237
Incline Global Management
New York
$32.1M +$10.9M +35,520 +43%
DekaBank Deutsche Girozentrale
238
DekaBank Deutsche Girozentrale
Germany
$31.9M +$9.62M +31,332 +34%
CB
239
Commerce Bank
Missouri
$31.9M +$200K +652 +0.6%
IGIM
240
I.G. Investment Management
Manitoba, Canada
$31.8M +$36M +117,048 New
AFG
241
Albion Financial Group
Utah
$31.4M -$249K -811 -0.7%
GIBU
242
Gulf International Bank (UK)
United Kingdom
$31.1M +$1.73M +5,620 +5%
Caisse de Depot et Placement du Quebec (CDPQ)
243
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$30.4M -$18.6M -60,500 -35%
Asset Management One
244
Asset Management One
Japan
$30.2M -$13M -42,443 -26%
Zurich Cantonal Bank
245
Zurich Cantonal Bank
Switzerland
$30.1M -$3.62M -11,794 -10%
ASRS
246
Arizona State Retirement System
Arizona
$29.7M +$33.6M +109,277 New
ECP
247
Empyrean Capital Partners
California
$29.6M -$103M -336,753 -76%
SGAM
248
Smith Group Asset Management
Texas
$29.5M -$4.94M -16,079 -13%
SI
249
Standard Investments
New York
$29.4M -$23.5M -76,592 -41%
RIM
250
Rainier Investment Management
Washington
$29.4M -$3.1M -10,100 -9%

AGN Hedge Fund Activity: Q3 2015 in Review

1,056 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2015, worth a combined $96.1B — down 6.9% from $103B a quarter earlier.

Buyers outnumbered sellers: 121 funds opened new AGN positions and 93 closed out — a net gain of 28 holders — while 402 added to existing stakes and 407 trimmed.

The largest buyer was Norges Bank, opening a new position worth an estimated $1.01B. The largest seller was Fidelity Investments, cutting an estimated $1.45B.

  • 1,056 institutional investors held Allergan plc (AGN) as of Q3 2015, up from 1,035 in Q2 2015.
  • Funds reported $96.1B of Allergan plc stock for Q3 2015, down 6.9% quarter-over-quarter.
  • 121 funds opened new Allergan plc positions in Q3 2015 and 93 closed out, a net change of +28 holders.
  • The largest Allergan plc buyer in Q3 2015 was Norges Bank, an estimated $1.01B added.
  • The largest Allergan plc seller in Q3 2015 was Fidelity Investments, an estimated $1.45B sold.

Based on aggregated 13F filings for Q3 2015.